Opendata, web and dolomites

TERES

Production back to Europe – through a novel/green manufacturing process of TERbinafine API synthESis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "TERES" data sheet

The following table provides information about the project.

Coordinator
SYNTHETICS INTERNATIONAL AG 

Organization address
address: LAUTENGARTEN STRASSE 14
city: BASEL
postcode: 4052
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Project website http://www.synthetics-int.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-05-01   to  2018-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SYNTHETICS INTERNATIONAL AG CH (BASEL) coordinator 50˙000.00

Map

 Project objective

Synthetics Int. AG is a Swiss company strongly R&D driven which holds a variety of IP/commercial processes in the chemical business focused on the custom manufacturing and multi-customer products for the fine chemical market and the supply of polyfunctional cross linkers, tailor made manufacturing equipment, and natural products for treatment of wood. With a consolidated 20 years of history, Synthetics is a reference in the fine chemistry market. Within this project, in order to improve the synthesis of one of the most efficient dermatologic antifungals in the market, Terbinafine Hydrochloride, Synthetics has developed TERES, an innovative manufacturing process for this API, achieving a cycle time reduction from 6 steps to 2 steps by using a clever catalyst in order to accelerate the reaction. This implies a lower operation time and, at the same time, raw materials savings and environmental costs reduction (water/air, energy, solvents and toxic products). In addition, a better impurity profile is achieved, what means less risk of side effects in the drug product and purifying costs reduction. Consequently, Synthetics can ease the move Terbinafine manufacturing back from India (currently 80% of production) to a manufacturing plant in Denmark with an extreme competitive pricing. 

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TERES" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "TERES" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

QTB4AMR (2019)

Utilizing an innovative chemical platform to defeat antimicrobial resistance

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More